November 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 13, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
Projections indicate that, arthroscopy devices industry is projected to rise from USD 25.03 billion in 2024 to USD 56.75 billion by 2034, reflecting a CAGR of 8.53% over the next decade. The increasing number of orthopedic surgeries, medical device advancements, and growing healthcare infrastructure drive the market....
November 01, 2025
Organ-on-a-chip (OoC) systems use tiny tissues in microfluidic chips to mimic human physiology. By improving drug development, accuracy, and cost efficiency, OoCs offer a more precise alternative to animal models. The FDA’s 2022 act supports using non-animal data for clinical trials, advancing research....
November 01, 2025
According to market projections, the global spectrometry market, valued at USD 20.41 billion in 2024, is anticipated to reach USD 43.93 billion by 2034, growing at a CAGR of 7.97% over the next decade. The growing research and development, increasing investments & collaborations, and the rising prevalence of chronic disorders drive the market....
November 01, 2025
Projections indicate that, the global virus filtration market will increase from USD 5.22 billion in 2024 to USD 13.7 billion by 2034, experiencing a CAGR of 10.5% over the next 10 years. The rapidly expanding biotechnology sector, increasing manufacturing of biotech products, and technological advancements drive the market....
November 01, 2025
The molecular cytogenetics market is growing due to the rising demand for cancer diagnosis, congenital syndrome detection, and personalized medicine. Key drivers include advances in genomics, increasing R&D, and government investments. Notable industry movements include new lab openings and acquisitions in diagnostic services....
November 01, 2025
The miRNA sequencing and assay market is growing with advancements in next-gen sequencing (NGS) to explore miRNA's role in gene regulation and disease. Recent funding rounds, like aceRNA's $6.1M raise and Regulus' $100M deal, highlight innovations. AI integration, like Biostate AI's RNAseq tools, further accelerates research....
November 01, 2025
RNA-based therapies are rapidly growing, offering new treatment possibilities for diseases like cancer, neurological disorders, and infections. Recent advancements in mRNA, ASO, and siRNA technologies have led to new approvals, with more in development. These therapies offer targeted, risk-free solutions with broad potential....
November 01, 2025
Based on market forecasts, the global cell counting market, projected at USD 10.24 billion in 2024, is expected to reach USD 22.85 billion by 2034, growing at a CAGR of 8.41% over the forecast period. The cell counting market is growing because incorporating cell counts into flow cytometry is an easy way to improve test results and potentially save...
November 01, 2025
According to forecasts, the global metabolomics market will grow from USD 3.21 billion in 2024 to USD 11.32 billion by 2034, with an expected CAGR of 13.43%. The growth of the metabolomics market is driven by the ability to provide details of metabolic states and global biochemical events affecting cells or biological systems....
November 01, 2025
Based on market forecasts, the digital PCR sector will expand from USD 7.15 billion in 2024 to USD 17.45 billion by 2034, experiencing a CAGR of 9.33%. The market is growing because digital PCR (dPCR) has many advantages, such as better accuracy, reproducibility, sensitivity, and inhibitor tolerance, as well as unique applications, including geneti...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com